WE CAN HELP
Book a FREE consultation  
For a free consultation or assistance, please call 020 7730 6666

Browse by Category

Hope for Cancer Hair Loss as FDA approves DigniCap Cold Caps

Thousands were given a ray of hope this week with the news that America’s Food and Drug Administration (FDA) had cleared a scalp-cooling device named the DigniCap for use on breast cancer patients. The device chills the scalp during chemotherapy so hair loss associated with the treatment can be minimised.

Hair loss is a common side-effect of chemotherapy treatment and many women with breast cancer agree that it significantly adds to the overall distress that comes with a diagnosis. Cold caps have now been in use for many years, but in some countries at a limited level. Having obtained its US patent in October 2015, this subsequent FDA clearing of the DigniCap for breast cancer patients is a first in the US and paves the way for much wider use.The Dignicap Scalp Cooling System

Tested in California

The Tech Times, reporting on the FDA’s decision, explains that the DigniCap Cooling System, manufactured by Swiss company Dignitana Inc, was tested at the University of California on 122 patients at four different medical centres. All participants had been diagnosed with breast cancer and were about to begin chemotherapy.

The treatment involves putting the cap on half an hour before the drugs are taken and it remains in place for around 90 minutes, by which time the effects of the drug in the blood start to diminish.

The science behind the device is relatively simple: the chilled scalp slows down the flow of blood (containing the chemotherapy drugs) to the hair follicles and in doing so it gives them a better chance of not being harmed.

In the Californian study, over two-thirds of patients maintained more than 50 per cent of their hair.

We are pleased to see a product for breast cancer patients that can minimise chemotherapy-induced hair loss and contribute to the quality of life of these individuals,” said Dr. William Maisel, Office of Device Evaluation’s acting director at the Centre for Devices and Radiological Health of the FDA. “Managing the side effects of chemotherapy is a critical component to overall health and recovery.”

Comfortable and user-friendly

DigniCap has previously been named the device of choice at CircleBath hospital in Somerset, whose staff tried the cap before offering it to patients. They said at the time that it was “eminently more comfortable and user-friendly” compared to others that they trialed.

Another popular maker of these cold caps is British firm Paxman, whose machines have been used on cancer patients since the late 1990s. Paxman is the original developer of the technology – derived from a beer cooler – and is one of the most widely-used brands in UK hospitals.

This week they will be presenting the results of the US clinical trials of the company’s new Orbis hair loss prevention system for early stage breast cancer patients at the San Antonio Breast Cancer Symposium. Paxman, too, is seeking FDA approval for its products and has been working with the medical body towards achieving this.


Belgravia CentreThe Belgravia Centre

The Belgravia Centre is the leader in hair loss treatment in the UK, with two clinics based in Central London. If you are worried about hair loss you can arrange a free consultation with a hair loss expert or complete our Online Consultation Form from anywhere in the UK or the rest of the world. View our Hair Loss Success Stories, which are the largest collection of such success stories in the world and demonstrate the levels of success that so many of Belgravia’s patients achieve. You can also phone 020 7730 6666 any time for our hair loss helpline or to arrange a free consultation.


Related Stories


Share this article

No Comments

No comments yet.

Comment on this article

* required field

Will not be published

Online Consultation

Submit an instant online consultation so that one of Belgravia’s hair loss specialists can diagnose your condition and recommend an effective course of treatment, wherever you live.

25 Mar

Biocellular Regenerative Alopecia Therapy Trial is Recruiting

Two novel treatment possibilities for Alopecia Areata – the autoimmune disorder that causes patchy hair loss – are to be combined for a new clinical trial, which is now recruiting participants. Announced by US-based stem cell specialists Regeneris Medical, the trial is broadly similar to one announced last year by another company and in which […]

Read full article »
24 Mar

Success Story Alert! New Male Hair Loss Treatment Entry

A new entry has just been added to Belgravia’s Male Hair Loss Treatment Success Stories gallery. After six months, this patient has seen improvement to the general density of his hair and is happy with the progress. Find out what this client had to say and see his regrowth results close up, or find out more […]

Read full article »
24 Mar

‘Can You Treat Hair Loss With Antihistamines?’

Name: Jamie Question: I read on a forum that hair loss can be treated with anti-histamines. Can you tell me which ones work best? should I use cream or tablets? Answer: Hi, Jamie. The use of the anti-histamines for hair loss is something that crops up often on internet forums, however the advice is often misleading. We do not advise using […]

Read full article »